GCHOY yields 2.54% · JNJ yields 2.13%● Live data
📍 GCHOY pulled ahead of the other in Year 1
Combined, GCHOY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GCHOY + JNJ for your $10,000?
Grupo Nutresa S. A. operates in the food industry primarily in Colombia and Latin America. The company produces and sells cold cuts, matured meats, sausages, canned vegetables, ready-to-eat dishes, and mushrooms; and biscuits, cookies flavored, creamed, and wafers cookies, as well as crackers. It also produces and sells chocolate candies, chocolate drinks, milk modifiers, and cereal bars and nuts; and instant cold beverages, tea, juices, coffee, pastas, snacks, edible oils, soups, and desserts, as well as freeze-dried, roasted, soluble, ground coffee, coffee-in powder, and coffee extracts and blends. In addition, the company offers ice cream products, including popsicles, milk popsicles, cones, liters, desserts, cups, and ice cream cookies; and short, long, and egg pasta, as well as pasta with vegetables, fiber pasta, pasta with butter, and instant pasta. Further, it operates restaurants and ice cream parlors, as well as provides logistics and transportation services. Grupo Nutresa S. A. was incorporated in 1920 and is based in Medellin, Colombia.
Full GCHOY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.